News tagged with hiv infection
Acne drug prevents HIV breakout (w/ Video)
Johns Hopkins scientists have found that a safe and inexpensive antibiotic in use since the 1970s for treating acne effectively targets infected immune cells in which HIV, the virus that causes AIDS, lies ...
Medicine & Health / HIV & AIDS
Mar 19, 2010 |
4.8 / 5 (21) |
1
|
New insights into the mystery of natural HIV immunity
(PhysOrg.com) -- When people become infected by HIV, it's usually only a matter of time, barring drug intervention, until they develop full-blown AIDS. However, a small number of people exposed to the virus ...
Medicine & Health / HIV & AIDS
May 05, 2010 |
5 / 5 (17) |
0
|
Report: Transplant may have cured man of AIDS
A very unusual blood transplant appears to have cured an American man living in Berlin of infection with the AIDS virus, but doctors say the approach is not practical for wide use. The man, who is in his 40s, had a blood ...
Medicine & Health / HIV & AIDS
Dec 15, 2010 |
5 / 5 (16) |
16
Scientists find antibodies that prevent most HIV strains from infecting human cells
Scientists have discovered two potent human antibodies that can stop more than 90 percent of known global HIV strains from infecting human cells in the laboratory, and have demonstrated how one of these disease-fighting ...
Medicine & Health / HIV & AIDS
Jul 08, 2010 |
4.9 / 5 (16) |
2
|
Stem-cell work closes a door to AIDS virus
Lab work on mice has opened up a novel way of closing a gateway to the AIDS virus, according to a study published on Friday.
Medicine & Health / HIV & AIDS
Jul 02, 2010 |
4.9 / 5 (8) |
1
Did the end of smallpox vaccination cause the explosive spread of HIV?
Vaccinia immunization, as given to prevent the spread of smallpox, produces a five-fold reduction in HIV replication in the laboratory. Researchers writing in the open access journal BMC Immunology suggest that the end of ...
Medicine & Health / HIV & AIDS
May 17, 2010 |
4.4 / 5 (7) |
0
New anti-HIV gene therapy makes T-cells resistant to HIV infection
An innovative genetic strategy for rendering T-cells resistant to HIV infection without affecting their normal growth and activity is described in a paper published in Human Gene Therapy, a peer-reviewed journal published by Mar ...
Medicine & Health / HIV & AIDS
Jan 26, 2011 |
5 / 5 (5) |
0
12 myths about HIV/AIDS and people who use drugs
In a Comment which forms part of the Series in Lancet, 12 myths about HIV/AIDS are debunked.
Medicine & Health / HIV & AIDS
Jul 20, 2010 |
4.8 / 5 (5) |
0
Study provides new insights into an ancient mechanism of mammalian evolution
A team of geneticists and computational biologists in the UK today reveal how an ancient mechanism is involved in gene control and continues to drive genome evolution. The new study is published in the journal ...
Jan 12, 2012 |
4.6 / 5 (5) |
0
|
Criminalization of drugs and drug users fuels HIV; laws should be reviewed, say experts (w/ Video)
Strict laws on the criminalisation of drug use and drug users are fuelling the spread of HIV and other serious harms associated with the criminal market and should be reviewed, say experts in a series of articles published ...
Medicine & Health / HIV & AIDS
Jul 14, 2010 |
4.4 / 5 (5) |
2
Researchers identify two FDA approved drugs that may fight HIV
Researchers at the University of Minnesota Academic Health Center have identified two drugs that, when combined, may serve as an effective treatment for HIV.
Medicine & Health / HIV & AIDS
Aug 20, 2010 |
3.7 / 5 (6) |
0
|
Scientists reveal criminal virus spreaders using evolutionary forensics
The source of HIV infection in two separate criminal cases in which men were convicted of intentionally infecting their female sexual partners was confirmed by scientists from The University of Texas at Austin and Baylor ...
Medicine & Health / Medical research
Nov 15, 2010 |
5 / 5 (4) |
4
|
HIV protein unveils vaccine target
(PhysOrg.com) -- An international study headed by a UC Davis scientist describes how a component of a potential HIV vaccine opens like a flower, undergoing one of the most dramatic protein rearrangements yet ...
Medicine & Health / HIV & AIDS
Mar 31, 2011 |
5 / 5 (4) |
0
|
Why so many antibodies fail to protect against HIV infection
Researchers have been stymied for years over the fact that people infected with the AIDS virus do indeed produce antibodies in response to the pathogen antibodies that turn out to be ineffective in blocking infection.
Medicine & Health / HIV & AIDS
Nov 18, 2010 |
4 / 5 (4) |
0
|
Novel microfluidic HIV test is quick and cheap
UC Davis biomedical engineer Prof. Alexander Revzin has developed a "lab on a chip" device for HIV testing. Revzin's microfluidic device uses antibodies to "capture" white blood cells called T cells that are ...
Chemistry / Analytical Chemistry
Jul 16, 2010 |
5 / 5 (3) |
0
|
HIV
Human immunodeficiency virus (HIV) is a lentivirus (a member of the retrovirus family) that causes acquired immunodeficiency syndrome (AIDS), a condition in humans in which the immune system begins to fail, leading to life-threatening opportunistic infections. Infection with HIV occurs by the transfer of blood, semen, vaginal fluid, pre-ejaculate, or breast milk. Within these bodily fluids, HIV is present as both free virus particles and virus within infected immune cells. The four major routes of transmission are unsafe sex, contaminated needles, breast milk, and transmission from an infected mother to her baby at birth (Vertical transmission). Screening of blood products for HIV has largely eliminated transmission through blood transfusions or infected blood products in the developed world.
HIV infection in humans is now pandemic. From 1981 to 2006, AIDS killed more than 25 million people. HIV infects about 0.6 percent of the world's population. In 2005 alone, AIDS claimed an estimated 2.4–3.3 million lives, of which more than 570,000 were children. A third of these deaths are occurring in sub-Saharan Africa, retarding economic growth and increasing poverty. According to current estimates, HIV is set to infect 90 million people in Africa, resulting in a minimum estimate of 18 million orphans. Antiretroviral treatment reduces both the mortality and the morbidity of HIV infection, but routine access to antiretroviral medication is not available in all countries.
HIV primarily infects vital cells in the human immune system such as helper T cells (specifically CD4+ T cells), macrophages, and dendritic cells. HIV infection leads to low levels of CD4+ T cells through three main mechanisms: firstly, direct viral killing of infected cells; secondly, increased rates of apoptosis in infected cells; and thirdly, killing of infected CD4+ T cells by CD8 cytotoxic lymphocytes that recognize infected cells. When CD4+ T cell numbers decline below a critical level, cell-mediated immunity is lost, and the body becomes progressively more susceptible to opportunistic infections.
Eventually most HIV-infected individuals develop AIDS. These individuals mostly die from opportunistic infections or malignancies associated with the progressive failure of the immune system. Without treatment, about 9 out of every 10 persons with HIV will progress to AIDS after 10–15 years. Many progress much sooner. Treatment with anti-retrovirals increases the life expectancy of people infected with HIV. Even after HIV has progressed to diagnosable AIDS, the average survival time with antiretroviral therapy (as of 2005) is estimated to be more than 5 years. Without antiretroviral therapy, death normally occurs within a year.
For more information about HIV, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.